Novo NordiskSee all their emailsNovo’s once-weekly Sogroya® (somapacitan) receives positive CHMP opinion in Europe for children with idiopathic short stature (unexplained shortness)
A real announcement email from Novo Nordisk. Captured September 18, 2026.
Make this email yours
Migma AI designs one like it with your logo, colors, and images.
About this email
Captured Announcement
Novo Nordisk announces a positive CHMP opinion in Europe for once-weekly Sogroya in children with idiopathic short stature.
Top-left logo, single-column text layout with dense corporate press release formatting, bullet points, quoted expert statements, contact details table, and extensive references at the bottom.
Color palette
Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.